SURGICAL MANAGEMENT OF FIGO STAGE IV EPITHELIAL OVARIAN CANCER VERSUS FIGO STAGE IIIC: THE REAL-WORLD EXPERIENCE FROM KEM

被引:1
|
作者
Tsibulak, Irina [1 ]
Moubarak, Malak [1 ]
Schneider, Stephanie [1 ]
Traut, Alexander [1 ]
Welz, Julia [1 ]
Concin, Nicole [1 ]
Bommert, Mareike [1 ]
Vrentas, Vasileios [1 ]
Zdanyte, Kristina [1 ]
Bennefeld, Luisa [1 ]
Kaiser, Sabrina [1 ]
Westermann, Timo [1 ]
Heitz, Florian [1 ]
Harter, Philipp [1 ]
机构
[1] Kiliniken Essen Mitte, Essen, Germany
关键词
D O I
10.1136/ijgc-2023-ESGO.58
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
644
引用
收藏
页码:A37 / A38
页数:2
相关论文
共 50 条
  • [21] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN FIGO STAGE III AND IV EPITHELIAL OVARIAN, TUBAL OR PERITONEAL CANCER
    Tzanis, A.
    Iavazzo, C. R.
    Hadjivasilis, A.
    Tsouvali, H.
    Antoniou, G.
    Antoniou, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A296 - A296
  • [22] A new prognostic model for FIGO stage 1 epithelial ovarian cancer
    Obermair, Andreas
    Fuller, Arlan
    Lopez-Varela, Elisa
    van Gorp, Toon
    Vergote, Ignace
    Eaton, Lynne
    Fowler, Jeff
    Quinn, Michael
    Hammond, Ian
    Marsden, Donald
    Proietto, Anthony
    Carter, Jonathan
    Davy, Margaret
    Tripcony, Lee
    Abu-Rustum, Nadeem
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 607 - 611
  • [23] Chemotherapy (CT) with radiotherapy versus CT alone for FIGO Stage IIIc endometrial cancer
    Matsuura, M.
    Suzuki, T.
    Morishita, M.
    Tanaka, R.
    Ito, E.
    Saito, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (01) : 40 - 44
  • [24] Ten years survival of FIGO Stage IIIC epithelial ovarian cancer cases due to lymph node metastases only
    Grossi, E.
    Noli, S.
    Scarfone, G.
    Villa, A.
    Parazzini, F.
    Cipriani, S.
    Bolis, G.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (06) : 615 - 616
  • [25] Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
    Ataseven, Beyhan
    Grimm, Christoph
    Harter, Philipp
    Heitz, Florian
    Traut, Alexander
    Prader, Sonia
    du Bois, Andreas
    GYNECOLOGIC ONCOLOGY, 2016, 140 (02) : 215 - 220
  • [26] Characteristics, Treatment Patterns and Survival of FIGO Stage IV Epithelial Ovarian Cancer - a Population Based Study
    Jakob, Dorothee
    Schmoor, Claudia
    Reuten, Raphael
    Frevert, Marie Louise
    Dannehl, Dominik
    Hermann, Silke
    Jungmann, Peter
    Breitbach, Moritz
    Hartkopf, Andreas
    Juhasz-Boss, Ingolf
    Taran, Florin-Andrei
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 95 - 95
  • [27] The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
    Ataseven, Beyhan
    Harter, Philipp
    Grimm, Christoph
    Heitz, Florian
    Heikaus, Sebastian
    Traut, Alexander
    Kahl, Annett
    Kurzeder, Christian
    Prader, Sonia
    du Bois, Andreas
    GYNECOLOGIC ONCOLOGY, 2016, 142 (02) : 243 - 247
  • [28] Impact from primary and recurrent treatment on survival of FIGO IIIc epithelial ovarian cancer patients
    Szczesny, Witold
    Vistad, Ingvild
    Kaern, Janne
    Nakling, Jakob
    Sandvik, Leiv
    Trope, Claes
    Paulsen, Torbjern
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice A Retrospective French Multicentric Study
    Luyckx, Mathieu
    Leblanc, Eric
    Filleron, Thomas
    Morice, Philippe
    Darai, Emile
    Classe, Jean-Marc
    Ferron, Gwenael
    Stoeckle, Eberhard
    Pomel, Christophe
    Vinet, Benedicte
    Chereau, Elisabeth
    Bergzoll, Cecile
    Querleu, Denis
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1337 - 1343
  • [30] Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?
    Mert, Ismail
    Kumar, Amanika
    Torres, Diogo
    Huang, Yajue
    McGree, Michaela E.
    Weaver, Amy L.
    Cliby, William A.
    GYNECOLOGIC ONCOLOGY, 2019, 153 (02) : 238 - 241